"Bone and Bones" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX.
| Descriptor ID |
D001842
|
| MeSH Number(s) |
A02.835.232 A10.165.265
|
| Concept/Terms |
Bone Tissue- Bone Tissue
- Bone Tissues
- Tissue, Bone
- Tissues, Bone
- Bony Apophyses
- Apophyses, Bony
- Bony Apophysis
- Apophysis, Bony
|
Below are MeSH descriptors whose meaning is more general than "Bone and Bones".
Below are MeSH descriptors whose meaning is more specific than "Bone and Bones".
This graph shows the total number of publications written about "Bone and Bones" by people in this website by year, and whether "Bone and Bones" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 1997 | 0 | 2 | 2 |
| 1998 | 3 | 1 | 4 |
| 2000 | 4 | 3 | 7 |
| 2001 | 1 | 2 | 3 |
| 2002 | 1 | 2 | 3 |
| 2003 | 1 | 2 | 3 |
| 2004 | 7 | 3 | 10 |
| 2005 | 5 | 2 | 7 |
| 2006 | 2 | 3 | 5 |
| 2007 | 9 | 3 | 12 |
| 2008 | 5 | 1 | 6 |
| 2009 | 2 | 2 | 4 |
| 2010 | 1 | 2 | 3 |
| 2011 | 2 | 3 | 5 |
| 2012 | 4 | 3 | 7 |
| 2013 | 4 | 2 | 6 |
| 2014 | 12 | 3 | 15 |
| 2015 | 11 | 0 | 11 |
| 2016 | 1 | 3 | 4 |
| 2017 | 11 | 5 | 16 |
| 2018 | 8 | 2 | 10 |
| 2019 | 6 | 8 | 14 |
| 2020 | 4 | 1 | 5 |
| 2021 | 5 | 10 | 15 |
| 2022 | 1 | 6 | 7 |
| 2023 | 2 | 4 | 6 |
| 2024 | 4 | 7 | 11 |
| 2025 | 3 | 0 | 3 |
| 2026 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bone and Bones" by people in Profiles.
-
Impact of mild autonomous cortisol secretion on bone density, metabolism, and microstructure: a cross-sectional study. J Clin Endocrinol Metab. 2026 Sep 16; 111(10):2913-2921.
-
Adverse effect of obesity and dysglycemia on bone microarchitecture and strength in youth: sex-related differences. J Clin Endocrinol Metab. 2026 Jul 15; 111(8):e1983-e1993.
-
Bone-derived Osterix+ osteolineage cells are a source of tumor-promoting myofibroblastic cancer-associated fibroblasts in breast cancer. Nat Commun. 2026 Jun 11; 17(1).
-
Stimulant Medications and Bone Health. Curr Osteoporos Rep. 2026 May 14; 24(1).
-
Pathways to Facilitate Early Recognition and Diagnosis of Hypochondroplasia. Adv Ther. 2026 May; 43(5):2018-2033.
-
Anti-transforming growth factor-? treatment shows increased bone mass and strength in a novel mouse model for osteogenesis imperfecta type I. J Bone Miner Res. 2025 Jun 25; 40(7):881-890.
-
High-Fidelity Finite Element Modeling Technique to Improve Sensitivity to Bone Tissue Changes of Older Adults with Obesity undergoing Intensive Lifestyle Intervention. Ann Biomed Eng. 2025 Sep; 53(9):2359-2371.
-
Pharmacogenetic and microRNA mechanisms of beta blocker use on bone. J Bone Miner Res. 2025 Feb 02; 40(2):231-240.
-
Differential bone calcium retention with the use of oral versus vaginal hormonal contraception: A randomized trial using calcium-41 radiotracer. Contraception. 2025 03; 143:110778.
-
Guidelines for the correct use of the nomenclature of biochemical indices of bone status: a position statement of the Joint IOF Working Group and IFCC Committee on Bone Metabolism. Clin Chem Lab Med. 2025 Mar 26; 63(4):704-711.